Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 436

1.

Identifying Outcomes that Are Important to Living Kidney Donors: A Nominal Group Technique Study.

Hanson CS, Chapman JR, Gill JS, Kanellis J, Wong G, Craig JC, Teixeira-Pinto A, Chadban SJ, Garg AX, Ralph AF, Pinter J, Lewis JR, Tong A.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):916-926. doi: 10.2215/CJN.13441217. Epub 2018 May 31.

PMID:
29853616
2.

Effect of Coaching to Increase Water Intake on Kidney Function Decline in Adults With Chronic Kidney Disease: The CKD WIT Randomized Clinical Trial.

Clark WF, Sontrop JM, Huang SH, Gallo K, Moist L, House AA, Cuerden MS, Weir MA, Bagga A, Brimble S, Burke A, Muirhead N, Pandeya S, Garg AX.

JAMA. 2018 May 8;319(18):1870-1879. doi: 10.1001/jama.2018.4930.

PMID:
29801012
3.

ESRD among Immigrants to Ontario, Canada: A Population-Based Study.

Perl J, McArthur E, Tan VS, Nash DM, Garg AX, Harel Z, Li AH, Sood MM, Ray JG, Wald R.

J Am Soc Nephrol. 2018 May 2. pii: ASN.2017101055. doi: 10.1681/ASN.2017101055. [Epub ahead of print]

PMID:
29720548
4.

Health care costs for the evaluation, surgery, and follow-up care of living kidney donors.

Habbous S, Sarma S, Barnieh L, McArthur E, Klarenbach S, Manns B, Begen MA, Lentine KL, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Transplantation. 2018 Apr 19. doi: 10.1097/TP.0000000000002222. [Epub ahead of print]

PMID:
29677068
5.

Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline.

Lentine KL, Levey AS, Garg AX; KDIGO Living Kidney Donor Work Group.

Am J Kidney Dis. 2018 Apr 11. pii: S0272-6386(18)30583-3. doi: 10.1053/j.ajkd.2018.01.059. [Epub ahead of print] No abstract available.

PMID:
29673725
6.

Nephrology comanagement and the quality of antibiotic prescribing in primary care for patients with chronic kidney disease: a retrospective cross-sectional study.

Zhu JXG, Nash DM, McArthur E, Farag A, Garg AX, Jain AK.

Nephrol Dial Transplant. 2018 Apr 12. doi: 10.1093/ndt/gfy072. [Epub ahead of print]

PMID:
29669046
7.

Validation of Living Donor Nephrectomy Codes.

Lam NN, Lentine KL, Klarenbach S, Sood MM, Kuwornu PJ, Naylor KL, Knoll GA, Kim SJ, Young A, Garg AX.

Can J Kidney Health Dis. 2018 Apr 9;5:2054358118760833. doi: 10.1177/2054358118760833. eCollection 2018.

8.

Identification of Patients Expected to Benefit from Electronic Alerts for Acute Kidney Injury.

Biswas A, Parikh CR, Feldman HI, Garg AX, Latham S, Lin H, Palevsky PM, Ugwuowo U, Wilson FP.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):842-849. doi: 10.2215/CJN.13351217. Epub 2018 Mar 29.

PMID:
29599299
9.

Duration of Living Kidney Transplant Donor Evaluations: Findings From 2 Multicenter Cohort Studies.

Habbous S, Arnold J, Begen MA, Boudville N, Cooper M, Dipchand C, Dixon SN, Feldman LS, Goździk D, Karpinski M, Klarenbach S, Knoll GA, Lam NN, Lentine KL, Lok C, McArthur E, McKenzie S, Miller M, Monroy-Cuadros M, Nguan C, Prasad GVR, Przech S, Sarma S, Segev DL, Storsley L, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2018 Mar 24. pii: S0272-6386(18)30126-4. doi: 10.1053/j.ajkd.2018.01.036. [Epub ahead of print]

10.

Potential implications of a more timely living kidney donor evaluation.

Habbous S, McArthur E, Sarma S, Begen MA, Lam NN, Manns B, Lentine KL, Dipchand C, Litchfield K, McKenzie S, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Transplant. 2018 Mar 25. doi: 10.1111/ajt.14732. [Epub ahead of print]

PMID:
29575655
11.

A Province-wide, Cross-sectional Study of Demographics and Medication Use of Patients in Hemodialysis Units Across Ontario.

Battistella M, Jandoc R, Ng JY, McArthur E, Garg AX.

Can J Kidney Health Dis. 2018 Mar 13;5:2054358118760832. doi: 10.1177/2054358118760832. eCollection 2018.

12.

Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease.

Habbous S, Przech S, Martin J, Garg AX, Sarma S.

Value Health. 2018 Mar;21(3):318-325. doi: 10.1016/j.jval.2017.08.3020. Epub 2017 Oct 18.

PMID:
29566839
13.

Gabapentin dose and the 30-day risk of altered mental status in older adults: A retrospective population-based study.

Fleet JL, Dixon SN, Kuwornu PJ, Dev VK, Montero-Odasso M, Burneo J, Garg AX.

PLoS One. 2018 Mar 14;13(3):e0193134. doi: 10.1371/journal.pone.0193134. eCollection 2018.

14.

Initiating maintenance dialysis prior to living kidney donor transplantation when a donor candidate evaluation is well underway.

Habbous S, McArthur E, Dixon SN, McKenzie S, Garcia-Ochoa C, Lam NN, Lentine KL, Dipchand C, Litchfield K, Begen MA, Sarma S, Garg AX.

Transplantation. 2018 Mar 10. doi: 10.1097/TP.0000000000002159. [Epub ahead of print]

PMID:
29538259
15.

Validity of administrative database code algorithms to identify vascular access placement, surgical revisions, and secondary patency.

Al-Jaishi AA, Moist LM, Oliver MJ, Nash DM, Fleet JL, Garg AX, Lok CE.

J Vasc Access. 2018 Mar 1:1129729818762008. doi: 10.1177/1129729818762008. [Epub ahead of print]

PMID:
29529926
16.

Association between Duration of Predialysis Care and Mortality after Dialysis Start.

Liu P, Quinn RR, Oliver MJ, Ronksley PE, Hemmelgarn BR, Quan H, Hiremath S, Bello AK, Blake PG, Garg AX, Johnson J, Verrelli M, Zacharias JM, Abd ElHafeez S, Tonelli M, Ravani P.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):893-899. doi: 10.2215/CJN.11951017. Epub 2018 Mar 5.

PMID:
29507006
17.

Canadians Seeking Solutions and Innovations to Overcome Chronic Kidney Disease (Can-SOLVE CKD): Form and Function.

Levin A, Adams E, Barrett BJ, Beanlands H, Burns KD, Chiu HH, Chong K, Dart A, Ferera J, Fernandez N, Fowler E, Garg AX, Gilbert R, Harris H, Harvey R, Hemmelgarn B, James M, Johnson J, Kappel J, Komenda P, McCormick M, McIntyre C, Mahmud F, Pei Y, Pollock G, Reich H, Rosenblum ND, Scholey J, Sochett E, Tang M, Tangri N, Tonelli M, Turner C, Walsh M, Woods C, Manns B.

Can J Kidney Health Dis. 2018 Jan 17;5:2054358117749530. doi: 10.1177/2054358117749530. eCollection 2018.

18.

Risk of rhabdomyolysis from 5-α reductase inhibitors.

Welk B, McArthur E, Ordon M, Dirk J, Dixon S, Garg AX.

Pharmacoepidemiol Drug Saf. 2018 Mar;27(3):351-355. doi: 10.1002/pds.4383. Epub 2018 Jan 25.

PMID:
29368380
19.

Development of biomarker combinations for postoperative acute kidney injury via Bayesian model selection in a multicenter cohort study.

Meisner A, Kerr KF, Thiessen-Philbrook H, Wilson FP, Garg AX, Shlipak MG, Kavsak P, Whitlock RP, Coca SG, Parikh CR.

Biomark Res. 2018 Jan 12;6:3. doi: 10.1186/s40364-018-0117-z. eCollection 2018.

20.

APOL1 Genotype and Renal Function of Black Living Donors.

Doshi MD, Ortigosa-Goggins M, Garg AX, Li L, Poggio ED, Winkler CA, Kopp JB.

J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.

PMID:
29339549

Supplemental Content

Loading ...
Support Center